Another patient has received a transplant with a genetically modified pig kidney. Tim Andrews, a 66-year-old who lives in ...

The surgery comes at a turning point in the quest to tell if animal-to-human transplants could help ease the shortage of ...

A biotechnology company in Research Triangle Park has taken a major step to develop a new option for patients in need of a ...

The recipient was Tim Andrews, a 66-year-old New Hampshire resident who had end-stage kidney disease and was on dialysis for ...

MONDAY, Feb. 10, 2025 (HealthDay News) -- Surgeons at Massachusetts General Hospital have successfully performed the fourth ...

Up to 50 transplant patients will receive a genetically modified pig kidney in a clinical trial that will launch this summer ...

The FDA has given approval for the first clinical trials of pig kidney transplants in humans, representing a significant advancement in addressing the organ shortage crisis.

The surgery highlights the potential of animal-to-human transplantation, with Andrews recovering well, showcasing promising ...

It’s too early to know how Andrews will fare but if the pig kidney were to fail, Riella said he’d still qualify for a human transplant and, now deemed inactive on the transplant list ...

FDA approves the first clinical trials for pig kidney transplants in humans, testing genetically modified pig organs.